EUVIMEDEUVIMED entdecken
Crossref

Expression of membrane-bound Interleukin-15 sustains the growth and survival of CAR-NK cells

Dongdong Feng, Lu Sun, Dongxue Hu, Jiamin Wu, Fangfang Xu, Xiangzhu Kong, Ruikang Yang, Guangyi Jiang, Liehao Jiang, Shu Wang, Weijia Fang, Jianqing Zhu und 2 weitere

International Immunopharmacology · 2025-12 · 166 · 115577

DOI: 10.1016/j.intimp.2025.115577 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2025-12. Verfasst von Dongdong Feng und 13 weiteren Autor:innen. Beteiligte Einrichtung: Otolaryngology & Head and Neck Center, Cancer Center, Department of Head and Neck Surgery, Zhejiang Provincial People's Hospital (Affiliated People's…. Hauptthemen laut MEDLINE: Interleukin-15, Killer Cells, Natural, Receptors, Chimeric Antigen, Immunotherapy, Adoptive. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Major Scientific and Technological Project of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Natural killer (NK) cells display a short lifespan in vivo without cytokine support. In the present study, we investigated whether the expression of a membrane-bound interleukin-15 (IL-15) on chimeric antigen receptor (CAR)-NK cells could help to overcome the hurdle. The CAR-NK cells were generated through electroporation of a piggyBac transposase plasmid and a bicistronic vector containing a 2nd generation natural killer group 2 member D (NKG2D) CAR gene and a cDNA fragment encoding human IL-15 linked to the CD8 hinge and transmembrane domain (membrane-bound interleukin-15, mbIL15), followed by repeated stimulation with K562 artificial antigen-presenting cells. This protocol resulted in a robust expansion of the CAR-NK cells up to 590,000-fold and CAR expression over 90 %. mbIL15 substantially enhanced the in vitro survival of the CAR-NK cells when being cultured without IL-2 support or in the presence of low concentrations of IL-2. Importantly, mbIL15 enhanced the in vivo survival of the CAR-NK cells in normal mice. In mice with tumors, the in vivo expansion of mbIL15/NKG2D CAR-NK cells was observable. These CAR-NK cells were effective in lysing target human cancer cells in vitro and in reducing tumor burden in a mouse xenograft model generated with human cancer cells expressing the NKG2D ligands. Our work provides empirical evidence that the co-expression of mbIL15 is a potential approach to improve the therapeutic potential of CAR-NK cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-15Killer Cells, NaturalReceptors, Chimeric AntigenImmunotherapy, AdoptiveNeoplasmsAnimalsHumansNK Cell Lectin-Like Receptor Subfamily KMiceK562 CellsCell SurvivalCell ProliferationFemale

Stichwörter der Autor:innen

CAR-NK cellsIL-15NKG2DOvarian cancer

Substanzen

Interleukin-15Receptors, Chimeric AntigenNK Cell Lectin-Like Receptor Subfamily KKLRK1 protein, humanIL15 protein, human

Autor:innen und Institutionen

  • Otolaryngology & Head and Neck Center, Cancer Center, Department of Head and Neck Surgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou 310014, Zhejiang, China…
  • Department of Gynaecologic Oncology, Zhejiang Cancer Hospital, Hangzhou 310022, China.
  • CNK Cell Therapeutics, #388, No 1 Avenue, Qiantang, Hangzhou 310018, China.
  • Department of Gynaecologic Oncology, Zhejiang Cancer Hospital, Hangzhou 310022, China; CNK Cell Therapeutics, #388, No 1 Avenue, Qiantang, Hangzhou 310018, China.
  • Department of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China; Zhejiang Provincial Key Laboratory for Drug Evaluation and Clinical Research, Hangzhou 31000…
  • Department of Gynaecologic Oncology, Zhejiang Cancer Hospital, Hangzhou 310022, China. Electronic address: zhujq@zjcc.org.cn.

Förderung

  • Major Scientific and Technological Project of Zhejiang Province

Zitieren

APA

Feng, D., Sun, L., Hu, D., Wu, J., Xu, F., Kong, X., Yang, R., Jiang, G., Jiang, L., Wang, S., Fang, W., Zhu, J., Du, Z., & Tan, Z. (2025). Expression of membrane-bound Interleukin-15 sustains the growth and survival of CAR-NK cells. International Immunopharmacology, 166, 115577. https://doi.org/10.1016/j.intimp.2025.115577

Vancouver

Feng D, Sun L, Hu D, Wu J, Xu F, Kong X, et al. Expression of membrane-bound Interleukin-15 sustains the growth and survival of CAR-NK cells. International Immunopharmacology. 2025;166:115577. doi:10.1016/j.intimp.2025.115577

BibTeX
@article{Feng2025,
  author = {Feng, Dongdong and Sun, Lu and Hu, Dongxue and Wu, Jiamin and Xu, Fangfang and Kong, Xiangzhu and Yang, Ruikang and Jiang, Guangyi and Jiang, Liehao and Wang, Shu and Fang, Weijia and Zhu, Jianqing and Du, Zhicheng and Tan, Zhuo},
  title = {Expression of membrane-bound Interleukin-15 sustains the growth and survival of CAR-NK cells},
  journal = {International Immunopharmacology},
  year = {2025},
  volume = {166},
  pages = {115577},
  doi = {10.1016/j.intimp.2025.115577}
}
Kostenlos starten →